INTRODUCTION
============

CD4 helper T cells play a significant role in regulating adaptive immune responses against foreign antigens. Once activated by the antigen, they differentiate into various types of T cells, including Th1, Th2, Th17, Th9, and T~reg~ cells, depend on environmental cytokines to control antigen-specific immune responses. IL-6 and IL-21 contribute to follicular helper T (T~FH~) cell differentiation when naive T cells are stimulated with T cell Receptor (TcR) and co-stimulatory molecules such as ICOS and CD28 ([@B1]). T~FH~ cells are a distinct subset of T cells by expressing Bcl-6 and are localized to B cell follicle in lymphoid organs with critical roles in the mediation of humoral adaptive immunity ([@B2],[@B3]).

Various cytokines, surface molecules, and transcription factors are reported to be involved in T~FH~ cell differentiation ([Fig. 1](#F1){ref-type="fig"}). IL-6 and IL-21 are critical cytokines for T~FH~ cell differentiation ([@B4]). Surface molecules, including ICOS, CD40L, PD-1, BTLA, and SAP are also important for T~FH~ cell differentiation and their functions ([@B5]). Inhibiting the interaction between CD40 and CD40L, or deficiency of ICOS or its ligand causes defects in formation of the germinal center (GC) ([@B6]) and T~FH~ cell differentiation ([@B7],[@B8]). In addition, SAP contributes to T~FH~ cell differentiation by maintaining stable T and B cell interaction ([@B6],[@B9]). Cytokine- and co-stimulatory molecule-mediated signaling pathways are essential for expression of the transcription factor B cell lymphoma-6 (Bcl-6), which is the master regulator of T~FH~ cell differentiation and is inhibited by the antagonizing transcription factor Blimp-1. Expression of Bcl-6 and Blimp-1 is reciprocally regulated during T cell differentiation ([@B1]).

Bcl-6-deficient T cells failed to differentiate into T~FH~ cells and the GC responses are hardly developed, demonstrating the absolute requirement for Bcl-6 ([@B2],[@B3]). T~FH~ cell differentiation program involves a dramatic change in surface expression of chemokine receptors. Reciprocal up-regulation of CXC-chemokine receptor 5 (CXCR5) and down-regulation of CCR7 enables T~FH~ cells to migrate into B cell follicles by responding to CXCL13, the ligand of CXCR5 ([@B10]-[@B12]). Inside of B cell follicles, T~FH~ cells provide B cell help signals by expressing co-stimulatory molecules and secreting cytokines such as IL-4 and IL-21, which are essential for germinal center B cells to undergo class switch recombination, somatic hyper-mutation, affinity maturation, and differentiation of plasma cells and memory B cells in the GC ([@B13]-[@B15]).

Recently, it was reported that some microRNAs (miRNAs) have a regulatory role in T~FH~ cell differentiation and the GC reaction. The miR-17-92 cluster acts as a positive regulator of T~FH~ cell differentiation via suppression of phosphatases that inhibits ICOS-mediated PI3K signaling pathways ([@B16]). In addition, the miR-17-92 cluster represses the expression of RORα, which induces inappropriate gene expression during T~FH~ cell differentiation ([@B17]). By contrast, miR-10a directly inhibits Bcl-6 expression ([@B18]), which strongly indicating that miRNAs are involved in dynamic regulation of T~FH~ differentiation.

If the GC reaction mediated by T~FH~ cells is dysregulated or if autoreactive T and B cells are activated, high levels of autoantibody can be accumulated through abnormal GC formation, which contributes to the development of autoimmune diseases ([@B19]). Thus, T~FH~ cells should be tightly regulated to prevent autoimmunity by limiting germinal center reactions to self antigen ([@B20]). Recently, follicular regulatory T (T~FR~) cells expressing CXCR5 were demonstrated to limit the GC reaction and reduce antibody production by migrating into B cell follicles ([@B21]). The regulation of germinal center reaction by T~FH~ and T~FR~ cells for normal immunity is summarized as figure ([Fig. 2](#F2){ref-type="fig"}).

In this review, we discuss the function of cytokines, transcription factors, and signaling pathways related to the differentiation or characteristics of T~FH~ cells. Additionally, we discuss the role of the GC reaction related to T~FH~ and T~FR~ cells in the maintenance of immune homeostasis and provide both a better understanding of the importance of T~FH~ cells in autoimmunity and their clinical relevance in human autoimmune diseases.

SIGNALING PATHWAYS REQUIRED FOR T~FH~ CELL DIFFERENTIATION
==========================================================

ICOS, PI3K, and Foxo1
---------------------

It has been reported that a strong interaction between the TcR and major histocompatibility complex (MHC) class II molecules triggers T~FH~ cell differentiation, which indicates that a strong TcR signal is essential for T~FH~ cell differentiation ([@B22]). In addition, among surface co-stimulatory molecules being expressed by T~FH~ cells, ICOS is induced when CD4 T cells become activated by recognizing antigen through TcRs, which then interact with ICOS-L that is expressed on B cells ([@B7],[@B11],[@B23],[@B24]). Its binding to the ligand ICOS-L triggers activation signals in a similar way to other members of CD28 family co-stimulatory receptors ([@B25],[@B26]). ICOS plays a significant role in increasing T cell proliferation and the production of cytokines, including IL-21 and IL-4 ([@B11],[@B27],[@B28]).

ICOS-mediated PI3K activation is crucial for T~FH~ cell differentiation, as a point mutation on the cytoplasmic tail of ICOS, where PI3K binds to and activates, led to a severely impaired T~FH~ cell differentiation of CD4 T cells ([@B28]). In contrast, overexpression of ICOS is sufficient to maintain T~FH~ cells in CD28-deficient mice ([@B7]). Among PI3K subunit p110γ appears to convey ICOS-mediated T~FH~ cell differentiation signaling pathway, as p110γ deficiency resulted in a defective T~FH~ cell differentiation, further strongly indicating that ICOS and PI3K are important for either differentiation or survival of T~FH~ cells. These results imply that ICOS-mediated PI3K signaling is crucial for the differentiation of T~FH~ cells ([@B25]). Moreover, Heping et al. reported that ICOS signaling is critical for motility of T~FH~ cells into the B cell follicle in a Bcl-6 independent manner ([@B29]).

PI3K signaling pathways following TcR and co-stimulation regulate the phosphorylation of Foxo1 to relocate it from the nucleus to the cytoplasm ([@B30],[@B31]). A recent study revealed that Foxo1 negatively regulates T cell activation and contributes to T cell tolerance ([@B32]). Foxo1-deficient CD4 T cells contribute to the development of autoimmune phenotypes including increased autoantibody production with reduced Foxp3^+^ regulatory T cell development and function, and augmented generation of T~FH~ cells and GC formation. In addition, the presence of Foxo-binding elements has been identified in the promoter region of Bcl-6 ([@B33]), which suggests that Foxo1 might act as a transcriptional repressor of Bcl-6 and, if so, Foxo1 might negatively regulate T~FH~ differentiation. Thus, ICOS and PI3K signaling is crucial for T~FH~ differentiation and Foxo1 could be a regulator of GC reaction.

IL-21, IL-6, and STATs
----------------------

IL-6 and IL-21 are well-known pro-inflammatory cytokines with important roles in Bcl-6 expression and T~FH~ cell differentiation ([@B4]). IL-21 induces B cell proliferation and class switch recombination and IL-21R is required for antibody response and GC formation ([@B34]). The IL-6-mediated STAT3 activation is also important for IL-21 expression in human and mouse naïve CD4 T cells upon TcR stimulation ([@B35],[@B36]). STAT3 is phosphorylated by JAK upon IL-6 stimulation, and activated STAT3 was shown to bind to Bcl-6 in T cells ([@B33]). IL-6 is an important factor for Bcl-6 induction in CD4 T cells during dendritic cell priming stage of CD4 T cell activation ([@B37]). However, other signaling pathways could compensate for IL-6 dependent T~FH~ differentiation pathway, as T~FH~ cells are normally found at the peak of the immune response to infection and immunization ([@B38],[@B39]). IL-6 signaling is required for IL-21 expression via c-Maf ([@B40]-[@B42]). Once being produced, IL-21 further increases its own production through a positive feedback mechanism ([@B43]).

Augmented IL-21 was reported to induce the expression of the master regulator for T~FH~ cell differentiation, Bcl-6 ([@B44]), while controversies exist whether IL-21 is a critical factor for Bcl-6 induction in CD4 T cells ([@B37]-[@B39]). At a downstream level, Choi et al. showed that IL-6-mediated STAT1 signaling can also prime T~FH~ cells by compensating for STAT3 and inducing Bcl-6 expression. Another recent study demonstrated that IL-12-mediated STAT4 signaling can induce expression of both Bcl-6 and T-bet, and T-bet inhibits the function of Bcl-6 ([@B45]). The balance between T-bet and Bcl-6 expression might be regulated by IL-2 concentration ([@B33]). Furthermore, IFN-γ was accounted to lead to abnormal T~FH~ cell differentiation in the sanroque mouse model ([@B46]). Given that IFN-γ induced Bcl-6 via pSTAT1 which binds to an IRE in an exon of Bcl-6 ([@B47]), IFN-γ could function as a positive regulator by directly inducing Bcl-6 expression in CD4 T cells. This supported by recent study by Lee et al., which demonstrated that T cell specific deletion of IFN-γR resulted in decreased T~FH~ cell differentiation in sanroque mice ([@B46]). Further studies are needed to clarify how this complex cytokine network regulates Bcl-6 expression and T~FH~ cell differentiation.

Bcl-6 and Blimp-1
-----------------

The zinc-finger-containing transcriptional repressor Bcl-6 was originally described as a key molecule in GC formation and B cell response ([@B48],[@B49]). Bcl-6-deficient mice cannot develop somatic hyper-mutation in B cell, result impaired GC formation ([@B50],[@B51]). In addition, B cells from these mice do not undergo affinity maturation, somatic hyper-mutation, and class switch recombination of immunoglobulin ([@B49]). Recently, Bcl-6 was identified as a crucial factor for T~FH~ cell differentiation ([@B3]). Bcl-6-deficient mice show impaired T~FH~ cell differentiation ([@B2]) and non-T~FH~ CD4 T cells do not express increased levels of Bcl-6 ([@B2],[@B52]). Bcl-6 directly inhibits a number of transcription factors, including T-bet and RORγt, which are key modulators of differentiation of Th1 and Th17 cells, respectively ([@B3]). Bcl-6 also inhibits expression of CCR7 and PSGL-1, which negatively regulate the migration of T cells into B cell follicles ([@B39],[@B53]). Moreover, Bcl-6 regulates the expression of various T~FH~ cell-related molecules, including ICOS, PD-1, PTLA, CD200, and SAP ([@B23]). Turner et al. identified the mouse form of Blimp-1, which is induced by cytokine-mediated B cell differentiation ([@B54]). Recent studies reported that the transcription factor Blimp-1 has an antagonistic role of Bcl-6 ([@B1],[@B52],[@B55]) and inhibits T~FH~ cell differentiation ([@B1]). Blimp-1 is highly expressed in non-T~FH~ effector T cells such as Th1, Th2, and Th17 cells ([@B1],[@B52]), whereas Bcl-6 is highly expressed only in T~FH~ cells. Moreover, constitutive expression of Blimp-1 inhibited T~FH~ cell formation ([@B1]) and Blimp-1 is important for terminal differentiation of both CD4^+^ and CD8^+^ T cells, which is characterized by high levels of effector molecule secretion and low proliferative potential ([@B52]). IL-2 mediated STAT5 signaling in activated CD4^+^ T cells induces expression of Blimp-1, which suppresses Bcl-6 and T~FH~ cell differentiation ([@B56]). High level of IL-2, especially in effector Th1 cells, induces T-bet, which also inhibits Bcl-6 expression and T~FH~ cell differentiation ([@B33]). Th1 cells might have the flexibility to regulate the expression of T-bet and Bcl-6 depending on environmental conditions ([@B33]). IL-6- and IL-21-mediated STAT3 signaling can also induce Blimp-1 or Bcl-6 ([@B57]) through the participation of additional transcription factors ([@B5]). To summarize, effector T cell fate seems to rely on the expression of Bcl-6 or Blimp-1 and they are reciprocally inhibit each other via complex signaling pathway, eventually act as a decision maker between T~FH~ cell and other effector T cell differentiation.

REGULATION OF T~FH~ CELL DIFFERENTIATION VIA T~FR~ CELL AND miRNA
=================================================================

Follicular regulatory T cells
-----------------------------

Foxp3-expressing regulatory T (T~reg~) cells contribute to the maintenance of immune tolerance by suppressing the dysregulated immune response to self-antigens ([@B58]). Scurfy mice without Foxp3^+^ T cells demonstrate severe systemic autoimmune phenotype. In addition, CD4 T cells isolated from scurfy mouse are hyper-responsive to TcR stimulation ([@B59],[@B60]).

It has been recently reported that the mice with CXCR5-deficient T~reg~ cells have more GC with augmented immunoglobulin production owing to the limited capability of these cells to migrate into B cell follicular region. This suggests that CXCR5 expression of T~reg~ cells is crucial for regulation of the GC reaction ([@B61]). In addition, T~reg~ cells expressing Bcl-6 and CXCR5, which originate from CXCR5-natural T~reg~ cell precursors, are found in GC ([@B21]). In the absence of CXCR5^+^Bcl-6^+^ T~reg~ cells, the GC reaction was not controlled efficiently leading to enhanced immunoglobulin production and increased B cell population in GCs. This result implies that T~reg~ cells expressing CXCR5 have important roles in regulation of the GC reaction. T~reg~ cells in GC are called follicular regulatory T (T~FR~) cells, which share characteristics of both T~FH~ and T~reg~ cells since Bcl-6, CD28 and SAP also affect development of T~FR~ cells. 5\~25% of T~FH~ cells expressing CXCR5 and PD-1 are also Foxp3^+^ T~FR~ cells and are located in the B cell follicle region ([@B62]). Recent study demonstrated that lack of the PD-1-PD-L1 pathway induced increase of T~FR~ cells and its suppressive ability, suggesting the regulatory role of PD-1 in the differentiation of T~FR~ cells ([@B63]). Co-transfer experiments with thymus-derived Foxp3^+^ CD4 T cells and Foxp3^-^ CD4 T cells into recipient demonstrated that Foxp3^+^ CD4 T cells become T~FR~ cells in mice immunized with antigen suggesting T~FR~ cells are derived from T~reg~ cell precursors. A recent study demonstrated Ag-specific antibody production was increased in the mice with Bcl-6-deficient T~reg~ cells ([@B21]). Furthermore, increased levels of high affinity antibody, plasma cells, and memory B cells are found in the mice demonstrating that T~FR~ cells expressing Bcl-6 control the GC reaction including plasma cell production and affinity maturation. By contrast, Blimp-1 down-regulates the number of T~FR~ cells, suggesting that Bcl-6 and Blimp-1 also reciprocally regulate differentiation of T~FH~ and T~FR~ cells to control the GC reaction ([@B1]). T~FR~ cells therefore seem to play a crucial role in the maintenance of immune tolerance, preventing autoimmune response by inhibiting the GC reaction and antibody production.

micro RNAs
----------

miRNAs are functional single stranded RNAs (ssRNAs), which are encoded endogenously, and are involved in immune cell development and differentiation ([@B64],[@B65]). Recent study reported that the miR-17-92 cluster was regulated by Bcl-6 in CD4 T cells ([@B3]). T cells overexpressing Bcl-6 demonstrated diminished expression of the miR-17-92 cluster, as do T~FH~ cells, which, suppresses the expression of CXCR5. However, several studies have shown that the miRNA-17-92 cluster induces T~FH~ cell differentiation ([@B16],[@B17]). T cell specific miR-17-92 transgenic mice demonstrate spontaneous Bcl-6 expression, T~FH~ cell differentiation, and GC formation ([@B16]). In contrast, miR-17-92-deficient mice show impaired T~FH~ cell differentiation during acute and chronic virus infection. The miR-17-92 cluster induces T~FH~ cell differentiation through suppression of PTEN and PHLPP2 expression, which regulate the ICOS-PI3K pathway. The miR-17-92 cluster also directly inhibits expression of RORα, which is involved in gene expression of non-T~FH~ effector T cell differentiation ([@B17]). In addition, miR-10a, which is specifically expressed in T~reg~ cells by TGF-β and retinoic acid, directly suppresses Bcl-6 expression ([@B18]). Some induced-T~reg~ (iT~reg~) cells migrate to GC in Peyer\'s patch and have T~FH~-like phenotypes. miR-10a expression is down-regulated in these iT~reg~ cells and overexpression of miR-10a significantly inhibits the conversion of iT~reg~ into T~FH~-like cells. More studies on the role of T~FR~ cells and miRNA in T~FH~ differentiation are needed to improve our understanding on dynamic regulation of germinal center reaction.

T~FH~ CELLS IN AUTOIMMUNE DISEASES
==================================

Systemic lupus erythematosus
----------------------------

Systemic lupus erythematosus (SLE) is an autoimmune disease with a complex phenotype that includes systemic inflammation, fever, fatigue, and chills ([@B66]). Diagnosis of SLE is very difficult because its phenotype overlaps with other diseases. Recent studies have suggested that the pathogenesis of SLE is profoundly related to T~FH~ cells ([@B44],[@B67],[@B68]). Spontaneous GC formation and autoantibody production have been reported in many mouse models of SLE ([@B44],[@B67]), suggesting that T~FH~ cells might be associated with pathogenesis of SLE. Indeed, recent studies demonstrated that T~FH~ cell differentiation is spontaneously induced in these mouse models ([@B44],[@B67],[@B68]). Also, dysregulated T~FH~ cell activity contributes to the pathogenesis of SLE through aberrant GC formation and massive production of autoantibodies, such as anti-dsDNA and ANA. T~FH~ cells induce these phenomena via cytokines and co-stimulatory molecules which stimulate B cells ([@B69],[@B70]). Autoimmune phenotypes were alleviated when T~FH~ cell differentiation was inhibited in sanroque mice, which have increased GC formation and T~FH~ cell differentiation ([@B70]). Linterman et al. crossed sanroque mice with IL-21- or SAP-deficient mice, or mice heterozygous for Bcl-6 to examine the role of Bcl-6 in development of the lupus-like phenotype ([@B71]). They found that the deficiencies of Bcl-6 or SAP ameliorate the lupus-like phenotype in sanroque mice IL-21 independently. However, lupus-like autoimmune phenotypes were reduced in another study when IL-21 signaling is not present in BXSB-Yaa mice, another mouse model of human SLE ([@B72]), recapitulating the complexity of pathogenesis of SLE in human. Remarkably, IL-21 expression was up-regulated in SLE patients than in healthy controls ([@B73]), and elevated production of T~FH~ relating factors such as CXCL13, BAFF were reported in human SLE patients ([@B74]). These results suggest that abnormal T~FH~ cell differentiation strongly related to SLE pathogenesis.

Rheumatoid arthritis
--------------------

Rheumatoid arthritis (RA) is an autoimmune disorder, which is recently studied that it is associated with dysregulated T~FH~ cell differentiation. Deborah et al. found that blockade of IL-21 signaling by IL-21R-Fc fusion protein treatment reduces disease severity in mouse and rat RA models ([@B75]). Furthermore, IL-21 blockade in animal models results in decreased IL-6 expression. A recent study by Victoratos et al. found that T~FH~ cells have a critical role in the maintenance of follicular dendritic cell (FDC)-mediated GC formation and autoantibody production in KRN/B mice that spontaneously develop RA ([@B76],[@B77]). In addition, Jang et al. reported that IL-21 receptor-deficient KBx/N mice have less severe RA with reduced T~FH~ cell population in draining lymph node ([@B43]). An IL-21R-Fc fusion protein that inhibits IL-21 signaling can delay disease onset and progression. Platt et al. also found increased T~FH~ cells and antibody production in an OVA-induced RA mouse model ([@B78]). In this study, they showed that abatacept, a fusion protein composed of the Fc region of IgG and the extracellular domain of CTLA-4 has a role in regulation of T~FH~ cell differentiation in OVA-induced RA mouse models. In human RA patients, up-regulated IL-21 level was reported with increased T~FH~-like cells that enhanced IL-21R expression ([@B79]). This increased T~FH~-like cells population correlated with enhanced 28-joint count disease activity score and anti-CCP antibody, which indicate disease severity.

Synthetically, T~FH~ cells seem to be involved in the pathogenesis of human autoimmune diseases such as SLE, RA, etc., therefore, regulation of T~FH~ cell differentiation could be an important strategy for the suppression of autoimmune diseases.

CONCLUSION
==========

Recently, characterization of T~FH~ cells and germinal center reaction has been highlighted in immunology field that T~FH~ cells have crucial roles in B cell response in adaptive immunity. IL-6 and IL-21 signaling induce expression of CXCR5, which enables the migration of T cells into B cell follicles with expressing Bcl-6, a master transcription factor for T~FH~ cell differentiation. These characteristics of T~FH~ cells distinguish them from other helper T cells. T~FH~ cells can induce affinity maturation, somatic hyper-mutation which mediate memory B cells and long-lived plasma cells with increased germinal centers. However, abnormally activated T~FH~ cell function give rise to an immune reaction against auto-antigens, and subsequently could trigger autoimmune diseases such as SLE, RA, etc. There are several ways including miRNAs, T~FR~ cells, and IL-21 blockade to potentially correct abnormal germinal center reaction by negatively regulating aberrant T~FH~ cell differentiation. Through better understanding of current knowledge of T~FH~ cell mediated dynamic germinal center reaction, we hope to discover novel therapeutic approaches by targeting T~FH~ cells in human autoimmune diseases.
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![Molecular mechanisms of Bcl-6 expression in T cells. Bcl-6, the master regulator of T~FH~ cell differentiation is controlled by a complex signaling pathway. Co-stimulatory molecules such as CD28 and ICOS activate PI3K to induce Bcl-6 expression. PTEN, PHLPP2 inhibit Bcl-6 expression through interfering PI3K signaling and Foxo1 directly inhibits Bcl-6 expression. Various cytokines, such as IL-6, IL-21, IL-12, and IFN-γ induce Bcl-6 expression through JAK-STAT signaling pathway while high level of IL-2 in combination with IL-12 induces T-bet to inhibit Bcl-6. Blimp-1 and Bcl-6 is reciprocally regulating each other to make a decision of effector T cell fate between T~FH~ and non-T~FH~ effector cells. Some miRNA such as miR-17-92 induces Bcl-6 expression by interfering phosphatases, which inhibit PI3K signaling pathway while miR-10a directly inhibits Bcl-6 expression.](in-14-21-g001){#F1}

![Germinal center reaction controlled by T~FH~ and T~FR~ cells. Naïve T cells following stimulation with TcR and co-stimulatory molecules with IL-6 and IL-21 by dendritic cells can differentiate into T~FH~ cells and migrate to the CXCL13-rich B cell follicle region. In the B cell follicle, T~FH~ cells interact with B cells via TcR and co-stimulatory molecules such as ICOS and CD40L. Upon interaction between T~FH~ cells and B cells, IL-4 and IL-21 from T~FH~ cells allow B cells to differentiate into memory B cells or plasma cells, which are involved in long-lasting antibody production. T~FR~ cells derived from nT~reg~ precursor cells from the thymus by expressing Bcl-6 and CXCR5 migrate to B cell follicle and inhibit both T~FH~ cell and B cell function.](in-14-21-g002){#F2}
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